Vashti C. Bryant, Ph.D.
|2011||University of Texas Medical Branch, Galveston, TX|
Area:Molecular Biology, Pharmaceutical Chemistry
Mean distance: (not calculated yet)
ParentsSign in to add mentor
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Radhakrishnan P, Bryant VC, Blowers EC, et al. (2013) Targeting the NF-ÎºB and mTOR pathways with a quinoxaline urea analog that inhibits IKKÎ² for pancreas cancer therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 2025-35|
|Rajule R, Bryant VC, Lopez H, et al. (2012) Perturbing pro-survival proteins using quinoxaline derivatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry. 20: 2227-34|
|Bryant VC, Kishore Kumar GD, Nyong AM, et al. (2012) Synthesis and evaluation of macrocyclic diarylether heptanoid natural products and their analogs. Bioorganic & Medicinal Chemistry Letters. 22: 245-8|
|Chen Q, Bryant VC, Lopez H, et al. (2011) 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study. Bioorganic & Medicinal Chemistry Letters. 21: 1929-32|
|Bryant VC, Radhakrishnan P, Hollingsworth MA, et al. (2011) Abstract LB-206: A novel scaffold that targets the IKK complex Cancer Research. 71|